AI-generated summary
The authors studied low fluence low-level laser (LFL), a non-invasive light treatment, in macrophages, dendritic cells and mice with tumours. They report that LFL increased MHC class II expression through a mitochondrial reactive oxygen species pathway involving Src, protein kinase C and CIITA, and that tumour growth was suppressed in mice. The findings come from cell and mouse experiments, and the abstract does not report human outcomes.
- Who or what was studied
- Macrophages and dendritic cells, plus CD11c-DTR and C57BL/6 mice with tumours
- Limits stated in the abstract
- The abstract reports cell and mouse work only, with no human data.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Reactive oxygen species, Fluence, Mitochondria, Phototherapy, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.